Portal Hypertension and Variceal Hemorrhage

Medical Clinics of North America

Volumn 92, Issue 3, 2008, Pages 551-574

  Toubia, Nagib ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCRILATE; CEPHALOSPORIN; ENBUCRILATE; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; LOSARTAN; NADOLOL; OCTREOTIDE; PLACEBO; PRAZOSIN; PROPRANOLOL; QUINOLONE; SOMATOSTATIN; TERLIPRESSIN; THROMBIN; VAPREOTIDE; VASOPRESSIN;

BACTERIAL PERITONITIS; CAUSAL ATTRIBUTION; CLINICAL TRIAL; COLLATERAL CIRCULATION; DRUG HALF LIFE; DRUG INHIBITION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; HUMAN; INTESTINE NECROSIS; LIVER CIRRHOSIS; META ANALYSIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH VARICES; SYSTEMATIC REVIEW; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; UNSPECIFIED SIDE EFFECT; VARICOSIS;

COLLATERAL CIRCULATION; DILATATION, PATHOLOGIC; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTATICS; HUMANS; HYPERTENSION, PORTAL; LIGATION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PYLORIC ANTRUM; RISK FACTORS; SCLEROTHERAPY; VASOPRESSINS;

EID: 41149133545     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2007.12.003     Document Type: Review

References (128)

1. Bosch J. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage. P R Health Sci J 19 (2000) 57-67
2. Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol 22 (2006) 254-262
3. Gupta P.S., Toruner M., Chung M., et al. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 41 (1998) 926-931
4. Shah V., Garcia-Cardena G, Sessa W., et al. The hepatic circulation in health and in disease: report of a single-topic symposium. Hepatology 27 (1998) 279-288
5. Sarin S., Groszmann R.T., and Mosca P. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 87 (1991) 1032-1036
6. Pinzani M., Milani S., De Franco R., et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110 (1996) 534-548
7. Rockey D.C., and Weisiger R.A. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 59 (1996) 233-240
8. Atucha N.M., Shah V., Garcia-Cardena G., et al. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 111 (1996) 1627-1632
9. Cahill P.A., Foster C., Redmond E.M., et al. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 22 (1995) 598-606
10. Cahill P.A., Redmond E.M., Hodges R., et al. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 25 (1996) 370-378
11. Garcia-Pagan J.C., Fernandez M., Bernadich C., et al. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am J Phys 267 (1994) G984-G990
12. Niederberger M., Gines P., Martin P.Y., et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24 (1996) 947-951
13. Sieber C.C., and Groszmann R.J. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Phys 262 (1992) G996-G1001
14. Sieber C.C., and Groszmann R.J. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 103 (1992) 235-239
15. Sieber C.C., Lopez-Talavera J.C., and Groszmann R.J. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 104 (1993) 1750-1754
16. Sogni P., Sabry S., Moreau R., et al. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J Hepatol 24 (1996) 487-490
17. Vorobioff J., Bredfeldt J.E., and Groszmann R.J. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 87 (1984) 1120-1126
18. Garcia-Pagan J.C., Groszmann R.J., and Bosch J. Measurement of portal pressure. Clin Gastroenterol Hepatol 981 (2005)
19. Groszmann R.J., Glickman M., and Blei A.T. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 76 (1979) 253-258
20. Vianna A., Hayes P.C., Moscoso G., et al. Normal venous circulation of the gastroesophageal junction: a route to understanding varices. Gastroenterology 93 (1987) 876-889
21. Garcia-Tsao G., Groszmann R.J., Fisher R.L., et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5 (1985) 419-424
22. Groszmann R.J., Garcia-Tsao G., Bosch J., et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353 (2005) 2254-2261
23. Escorsell A., Gines A., Llach J., et al. Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices. Hepatology 36 (2002) 936-940
24. Rigau J., Bosch J., Bordas J.M., et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology 96 (1989) 873-880
25. Beppu K., Inokuchi K., Koyanagi N., et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27 (1981) 213-218
26. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al., Practice Guidelines Committee of the Americal Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 (2007) 922-938
27. Konishi Y., Nakamura T., Kida H., et al. Catheter US probe EUS evaluation of gastric cardia and perigastric vascular structures to predict esophageal variceal recurrence. Gastrointest Endosc 55 (2002) 197-203
28. Eisen G.M., Eliakim R., and Zaman A. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 38 (2006) 31-35
29. Lapalus M.G., Dumortier J., Fumex F., et al. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy 38 (2006) 36-41
30. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 319 (1988) 983-989
31. Smith J.L., and Graham D.Y. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 82 (1982) 968-973
32. Sanyal A.J., Fontana R., and Di Bisceglie A.M. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 64 (2006) 855-864
33. D'Amico G., Pagliaro L., and Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19 (1999) 475-505
34. Feu F., Garcia-Pagan J.C., Bosch J., et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 346 (1995) 1056-1059
35. Groszmann R.J., Bosch J., Grace N.D., et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99 (1990) 1401-1407
36. Albillos A., Lledo J.L., Rossi I., et al. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 109 (1995) 1257-1265
37. Schneider A.W., Kalk J.F., and Klein C.P. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29 (1999) 334-339
38. Gonzalez-Abraldes J., Albillos A., Banares R., et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 121 (2001) 382-388
39. Schepke M., Werner E., Biecker E., et al. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 121 (2001) 389-395
40. Fiorucci S., Antonelli E., Morelli O., et al. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A 98 (2001) 8897-8902
41. Paquet K.J. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices: a prospective controlled randomized trial. Endoscopy 14 (1982) 4-5
42. Piai G., Cipolletta L., Claar M., et al. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology 8 (1988) 1495-1500
43. Witzel L., Wolbergs E., and Merki H. Prophylactic endoscopic sclerotherapy of oesophageal varices: a prospective controlled study. Lancet 1 (1985) 773-775
44. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease: a randomized, single-blind, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. N Engl J Med 324 (1991) 1779-1784
45. Santangelo W.C., Dueno M.I., Estes B.L., et al. Prophylactic sclerotherapy of large esophageal varices. N Engl J Med 13 (1988) 814-818
46. Fardy J.M., and Laupacis A. A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 89 (1994) 1938-1948
47. Lay C.S., Tsai Y.T., Teg C.Y., et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 25 (1997) 1346-1350
48. Lo G.H., Lai K.H., Cheng J.S., et al. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol 31 (1999) 451-456
49. Sarin S.K., Guptan R.K., Jain A.K., et al. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol 8 (1996) 337-342
50. De B.K., Ghoshal U.C., Das T., et al. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 14 (1999) 220-224
51. Imperiale T.F., and Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33 (2001) 802-807
52. Sarin S.K., Lamba G.S., Kumar M., et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 340 (1999) 988-993
53. Kravetz D., Bosch J., Arderiu M., et al. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology 9 (1989) 808-814
54. Kravetz D., Sikuler E., and Groszmann R.J. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology 90 (1986) 1232-1240
55. Youssef W.I., Salazar F., Dasarathy S., et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98 (2003) 1391-1394
56. Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
57. Bernard B., Cardanel J.F., and Valla. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 108 (1995) 1828-1834
58. Goulis J., Armonis A., Patch D., et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27 (1998) 1207-1212
59. Bernard B., Grange J.D., Khac E.N., et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis. Digestion 59 Suppl 2 (1998) 54-57
60. Reichen J. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 11 (1990) 1066-1078
61. Escorsell A., Ruiz del Arbol L., Planas R., et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 32 (2000) 471-476
62. Bosch J., Kravetz D., and Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 80 (1981) 518-525
63. Villanueva C., Ortiz J., Minana J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121 (2001) 110-117
64. Buonamico P., Sabba C., Garcia-Tsao G., et al. Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study. Hepatology 21 (1995) 134-139
65. Abraldes J.G., and Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 35 (2002) 1305-1312
66. Jenkins S.A., Baxter J.N., Corbett W., et al. Efficacy of somatostatin and vasopressin in the control of acute variceal hemorrhage. Hepatology 5 (1985) 344-345
67. Cales P., Masliah C., Bernard B., et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 344 (2001) 23-28
68. D'Amico G., Pietrosi G., Tarantino I., et al. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 124 (2003) 1277-1291
69. Kahn D., Jones B., and Bornman P.C. Incidence and management of complications of injection sclerotherapy: a ten-year prospective evaluation. Surgery 105 (1989) 160-165
70. Laine L., and Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 123 (1995) 280-287
71. Banares R., Albillos A., Rincon D., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35 (2002) 609-615
72. D'Amico G., Pagliaro L., and Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 22 (1995) 332-354
73. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33 (2000) 846-852
74. D'Amico G., and De Franchis R. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
75. Moitinho E., Escorsell A., Bandi J.C., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117 (1999) 626-631
76. Cook D., and Laine L. Indications, technique, and complications of balloon tamponade for variceal gastrointestinal bleeding. J Intensive Care Med 7 (1992) 212-218
77. Azoulay D., Castaing D., Majno P., et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35 (2001) 590-597
78. Sanyal A.J., Freedman A.M., Luketic V.A., et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 111 (1996) 138-146
79. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (2000) 864-871
80. Graham D.Y., and Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology 80 (1981) 800-809
81. de Franchis R., and Primignani M. Why do varices bleed?. Gastroenterol Clin North Am 21 (1992) 85-101
82. McCormick P.A., Jenkins S.A., McIntyre N., et al. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut 36 (1995) 100-103
83. de Dombal F.T., Clarke J.R., Clamp S.E., et al. Prognostic factors in upper G.I. bleeding. Endoscopy 18 Suppl 2 (1986) 6-10
84. Lo G.H., Lai K.H., Cheng J.S., et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32 (2000) 461-465
85. Patch D., Sabin C.A., and Goulis J. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal re-bleeding in patients with cirrhosis. Gastroenterology 123 (2002) 1013-1019
86. Villanueva C., Minana J., Ortiz J., et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 345 (2001) 647-655
87. Luca A., D'Amico G., La Galla R., et al. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 212 (1999) 411-421
88. Meddi P., Merli M., Lionetti R., et al. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Hepatology 29 (1999) 1074-1077
89. Kage M., Korula J., Harada A., et al. Effects of sodium tetradecyl sulfate endoscopic variceal sclerotherapy on the esophagus: a prospective clinical and histopathologic study. J Clin Gastroenterol 9 (1987) 635-643
90. Sarin S.K., Sachdev G., and Nanda R. Follow-up of patients after variceal eradication: a comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Ann Surg 204 (1986) 78-82
91. Korula J., and Ralls P. The effects of chronic endoscopic variceal sclerotherapy on portal pressure in cirrhotics. Gastroenterology 101 (1991) 800-805
92. Hashizume M., Kitano S., and Yamago H. Endoscopic classification of gastric varices. Gastrointest Endosc 36 (1990) 276-280
93. Hosking S.W., and Johnson A.G. Gastric varices: a proposed classification leading to management. Br J Surg 75 (1988) 195-196
94. Korula J., Chin K., Ko Y., et al. Demonstration of two distinct subsets of gastric varices: observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci 36 (1991) 303-309
95. Ryan B.M., Stockbrugger R.W., and Ryan J.M. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 126 (2004) 1175-1189
96. Sarin S.K., Lahoti D., Saxena S.P., et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16 (1992) 1343-1349
97. Chang K.Y., Wu C.S., and Chen P.C. Prospective, randomized trial of hypertonic glucose water and sodium tetradecyl sulfate for gastric variceal bleeding in patients with advanced liver cirrhosis. Endoscopy 28 (1996) 481-486
98. Ciuh K.W., Changchien C.S., and Chuah S.K. Endoscopic imjection sclerotherapy with 1.5% sotradecol for bleeding gastric varices. J Clin Gastroenterol 24 (1997) 161-164
99. Gimson A.E., Westaby D., and Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 13 (1991) 274-278
100. Ogawa K., Ishikawa S., Naritaka Y., et al. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol 14 (1999) 245-250
101. Oho K., Iwao T., Sumino M., et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 27 (1995) 349-354
102. Sarin S.K. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 46 (1997) 8-14
103. Trudeau W., and Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 32 (1986) 264-268
104. Shiha G., and El-Sayed S.S. Gastric variceal ligation: a new technique. Gastrointest Endosc 49 (1999) 437-441
105. Takeuchi M., Nakai Y., and Syu A. Endoscopic ligation of gastric varices. Lancet 348 (1996) 1038
106. Vitte R.L., Eugene C., and Fingerhut A. Fatal outcome following endoscopic fundal variceal ligation. Gastrointest Endosc 43 (1996) 82
107. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33 (2001) 1060-1064
108. Sarin S.K., Jain A.K., Jain M., et al. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 97 (2002) 1010-1015
109. Tan P.C., Hou M.C., Lin H.C., et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 43 (2006) 690-697
110. Rengstorff D.S., and Binmoeller K.F. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans. Gastrointest Endosc 59 (2004) 553-558
111. Boyer T.D. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 124 (2003) 1700-1710
112. Chikamori F., Kuniyoshi N., and Shibuya S. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 129 (2001) 414-420
113. Kanagawa H., Mima S., Kouyama H., et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 11 (1996) 51-58
114. Shiba M., Higuchi K., Nakamura K., et al. Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial. Gastrointest Endosc 56 (2002) 522-528
115. Hosking S.W., Smart H.L., Johnson A.G., et al. Anorectal varices, haemorrhoids, and portal hypertension. Lancet 1 (1989) 349-352
116. Weisner R.H., LaRusso N.F., and Dozois R.R. Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology 90 (1986) 316-322
117. Kinkhabwala M. Bleeding ileal varicosity demonstrated by transhepatic portography. Am J Roentgenol 129 (1977) 514-516
118. Barbish A.W., and Ehrinpreis M.N. Successful endoscopic injection sclerotherapy of a bleeding duodenal varix. Am J Gastroenterol 88 (1993) 90-92
119. Bhasin D.K., Sharma B.C., Sriram P.V., et al. Endoscopic management of bleeding ectopic varices with histoacryl. HPB Surg 11 (1999) 171-173
120. Jabbari M., Cherry R., and Lough J.O. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 87 (1984) 1167-1170
121. Toyota M., Hinoda Y., and Nakagawa N. Gastric antral vascular ectasia causing severe anemia. J Gastroenterol 31 (1996) 710-713
122. Fisher N.C. Gastric antral vascular ectasia and its relation with portal hypertension. Gut 46 (2000) 441-442
123. Spahr L., Villeneuve J.P., Dufresne M.P., et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44 (1999) 739-742
124. Iwao T., Toyonaga A., Sumino M., et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 102 (1992) 2060-2065
125. Primignani M., Carpinelli L., Preatoni P., et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119 (2000) 181-187
126. Perez-Ayuso R.M., Pique J.M., Bosch J., et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337 (1991) 1431-1434
127. Trevino H.H., Brady III C.E., and Schenker S. Portal hypertensive gastropathy. Dig Dis 14 (1996) 258-270
128. Fleig W. Upper gastrointestinal hemorrhage from "downhill" esophageal varices. Dig Dis Sci 27 (1982) 23-27